ARNOLD O. BECKMAN CONFERENCE
Drugs and Toxins in Clinical Laboratory Practice
February 4 - 5, 1996--San Diego, CA
-----------------------------------------------------------------
SUNDAY, FEBRUARY 4, 1996
7:00amRegistration
OPENING SESSION
8:15amWelcome & Opening Remarks Robert Rej, Ph.D., Committee Chairman
8:30amClinical Assessment of Drug Toxicity and Safety in Humans Wayne Ray, Ph.D., Vanderbilt University Medical Center, Nashville, Tennessee
SESSION I - TOXIC SIDE EFFECTS IN THERAPY
Moderator: Mario Werner, M.D.
9:15amTitrating Cardiovascular Drugs Frank I. Marcus, M.D., University of Arizona College of Medicine, Tucson, Arizona
10:00amBreak
10:30amToxic Effects of Immunosuppressive Drugs: Mechanisms and Strategies for Controlling Them Leslie M. Shaw, Ph.D., University of
Pennsylvania Medical Center, Philadelphia, Pennsylvania
11:15amToxicity of Antineoplastic Drugs Bruce Chabner, M.D., Massachusetts General Hospital, Boston, Massachusetts
12:00noonLunch
SESSION II - EPIDEMIOLOGICAL AND LEGAL ASPECTS OF DRUGS OF ABUSE
Moderator: Edward R. Ashwood, M.D.
1:30pmEpidemiology of Illicit and Abused Drugs in Arrestees and Emergency Department Patients Compared to the General Population Beatrice A.
Rouse, Ph.D., U.S. Dept of Health and Human Services, Rockville, Maryland
2:15pmThe Role of the Clinical Toxicologist in Court R. Thomas Chamberlain, J.D., Ph.D., SmithKline Beecham Clinical Laboratories, Tampa, Florida
S.
3:00pmBreak
3:30pm-5:00pmCase Studies
6:00pm-7:00pmReception
MONDAY, FEBRUARY 5, 1996
SESSION III - TOXICITY AND CHRONIC EXPOSURE
Moderator: Robert Rej, Ph.D.
8:00amThe Health Consequences of Short- and Long-Term Postmenopausal Hormone Therapy Noel S. Weiss, M.D., Ph.D., University of Washington,
Seattle, Washington
8:45amLong-Term Exposure to Environmental Contaminants: Is There an Impact on Human Health? Jay B. Silkworth, Ph.D., General Electric
Corporation, Schenectady, New York
9:30amBreak
10:00amThe Cause and Prevention of Degenerative Diseases: Which Toxins Matter? Bruce N. Ames, Ph.D., University of California, Berkeley,
California
11:00am-12:30pmCase Studies
12:30pmLunch (on own)
SESSION IV - EMERGENCY TOXICOLOGY
Moderator: Martin H. Kroll, M.D.
2:00pmToxic Syndromes Horace K. Liang, M.D., Johns Hopkins Hospital, Baltimore, Maryland
2:45pmPediatric Poisonings Julius Goepp, M.D., Johns Hopkins Hospital, Baltimore, Maryland
3:30pmBreak
4:00pmAdvances in Poison Management, Toxic Syndromes, and Drugs of Abuse Marc J. Bayer, M.D., University of Connecticut Health Center,
Farmington, Connecticut
4:45pm-5:00pmClosing Remarks
CONTINUING MEDICAL EDUCATION
AACC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor Continuing Medical Education for physicians.
The AACC designates this continuing medical education activity for 12 credit hours in Category 1 of the Physician's Recognition Award of the
American Medical Association.
This program is approved by the AACC for 12 Category 1 ACCENT(r) credit hours toward the Clinical Chemists' Recognition Award.
ACCOMMODATIONS
A block of rooms is being held for conference attendees at the Wyndham Emerald Plaza, San Diego, California. Located at the heart of San Diego's
vibrant, new downtown, The Wyndham offers guests immediate access to all the city has to offer. Shopping, dining and nightclubs are within walking
distance. The San Diego Zoo, Sea World, Old Town and many other attractions are only a 5-10 minute drive.
The special conference rate is $129 for a single room and $144 for a double room. Reservations may be made by calling the Wyndham at 619-239-4500.
Identify yourself as attending the AACC Beckman Conference to reserve your room at the special rate. Rooms must be reserved by January 10, 1996
to ensure availability.
REGISTRATION
Prior to January 16, the registration fee is $350 for AACC members and $400 for non-members. After January 16, all fees are increased by $50. Please
contact AACC Customer Service (see below) for a registration brochure.
FOR ADDITIONAL INFORMATION, CONTACT:
AACC Customer Service
2101 L Street, NW, Suite 202
Washington, DC 20037-1526
800-892-1400, 202-857-0717, FAX: 202-833-4576
